Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marie-Aude Lefrère-Belda is active.

Publication


Featured researches published by Marie-Aude Lefrère-Belda.


European Journal of Endocrinology | 2009

Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure

Anne Bachelot; A. Rouxel; Nathalie Massin; Jérôme Dulon; Carine Courtillot; Christine Matuchansky; Yasmina Badachi; Anne Fortin; B. Paniel; Fabrice Lecuru; Marie-Aude Lefrère-Belda; Elisabeth Constancis; Elisabeth Thibault; Geri Meduri; Anne Guiochon-Mantel; Micheline Misrahi; Frédérique Kuttenn; Philippe Touraine

OBJECTIVE Premature ovarian failure (POF) encompasses a heterogeneous spectrum of conditions, with phenotypic variability among patients. The etiology of POF remains unknown in most cases. We performed a global phenotyping of POF women with the aim of better orienting attempts at an etiological diagnosis. DESIGN AND METHODS We performed a mixed retrospective and prospective study of clinical, biological, histological, morphological, and genetic data relating to 357 consecutive POF patients between 1997 and 2008. The study was conducted at a reproductive endocrinology referral center. RESULTS Seventy-six percent of the patients presented with normal puberty and secondary amenorrhea. Family history was present in 14% of the patients, clinical and/or biological autoimmunity in 14.3%. Fifty-six women had a fluctuating form of POF. The presence of follicles was suggested at ultrasonography in 50% of the patients, and observed in 29% at histology; the negative predictive value of the presence of follicles at ultrasonography was 77%. Bone mineral density alterations were found in 58% of the women. Eight patients had X chromosomal abnormalities other than Turners syndrome, eight other patients evidenced FMR1 pre-mutation. Two other patients had autoimmune polyendocrine syndrome type 2 and 1. CONCLUSION A genetic cause of POF was identified in 25 patients, i.e. 7% of the whole cohort. POF etiology remains most often undiscovered. Novel strategies of POF phenotyping are in such content mandatory to improve the rate of POF patients for whom etiology is identified.


Journal of Obstetrics and Gynaecology Research | 2012

Value of three-dimensional contrast-enhanced power Doppler ultrasound for characterizing adnexal masses

Cyrille Huchon; Ulrike Metzger; Anne-Sophie Bats; C. Bensaid; Gilles Chatellier; Michel Azizi; Marie-Aude Lefrère-Belda; Arnaud Dujardin; J. Bernard; F. Lecuru

Aims:  The aim of this study was to assess the diagnostic performance of 3‐D contrast‐enhanced power Doppler ultrasonography (3‐D CEPDUS) for differentiating benign and malignant adnexal masses.


Gynecologic and Obstetric Investigation | 2004

Sono-Guided Endometrial Biopsy: Comparison with Hysteroscopy Biopsy

Ulrike Metzger; J. P. Bernard; Sophie Camatte; Loic Lelievre; François Robin; Marie-Aude Lefrère-Belda; Fabrice Lecuru

Objective: To assess the feasibility, tolerance and diagnostic accuracy of endometrial biopsy (EB) during sonohysterography (SH) compared to EB after hysteroscopy (HSC) in endometrial disorders. Methods: 105 consecutive patients with irregular uterine bleeding were included prospectively in the calendar year 2001. SH and flexible HSC were performed in an office setting, subsequently and in a random order, by two different practitioners blind to the former experiment. SH-EB was performed using a 3.1-mm ultrasound-guided Bernard catheter in the uterine cavity still partly distended and with a gentle 20-ml syringe vacuum aspiration. The biopsy was directed on focal lesions or else randomly when no targets had previously been found. A Cornier Pipelle® was used to perform EB after HSC. We investigated all patients by biopsy, independent of the endometrial thickness. HSC-EB was the gold standard. Results: For both methods, cervical catheterism was impossible in 20 patients, 75 of them successfully underwent both exams. Duration and tolerance were similar. SH was effective in the distinction between normal and pathologic cavities, as well as in the diagnosis of polyps. Endometrium appeared significantly thinner with HSC (1.8 mm) when compared to SH (2.9 mm, p < 0.05). Histological endometrial assessment failed in 30 cases of SH-EB and in 22 cases in HSC-EB (NS). There was a poor correlation of the histological results of both techniques. Hyperplasia has never been diagnosed by SH-EB, whereas 3 EB issued from HSC-EB brought up this diagnosis. Conclusion: SH-EB with our technique did not improve the diagnostic potential of SH and severe diagnosis was missed. Histological assessment should fail less when we exclude endometrial atrophy. The diameter of the catheter and the aspiration technique must be revised and the learning curve must be considered. Our technique cannot replace EB by HSC.


Cancer Immunology, Immunotherapy | 2011

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

S. Oudard; Olivier Rixe; Benoit Beuselinck; Claude Linassier; Eugeniu Banu; Jean-Pascal Machiels; Marion Baudard; François Ringeisen; Thierry Velu; Marie-Aude Lefrère-Belda; Jean-Marc Limacher; Wolf H. Fridman; Michel Azizi; Bruce Acres; Eric Tartour


Gynecologic Oncology | 2007

Sentinel lymph node biopsy improves staging in early cervical cancer

Anne-Sophie Bats; Denys Clément; Florence Larousserie; Marie-Aude Lefrère-Belda; Marc Faraggi; Marc Froissart; F. Lecuru


Investigational New Drugs | 2015

Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation.

Pierre Combe; Laure Chauvenet; Marie-Aude Lefrère-Belda; Hélène Blons; Caroline Rousseau; S. Oudard; Eric Pujade-Lauraine


Bulletin Du Cancer | 2007

Comparison of different approaches in surgical management of early endometrial cancer

Anne-Sophie Bats; Gilles Chatellier; Denys Clément; Florence Larousserie; Marie-Aude Lefrère-Belda; Fabrice Lecuru; Claude Nos


La Revue du praticien | 2004

[Ovarian cancer: diagnosis of early stages, referral of patients and management].

Fabrice Lecuru; Ulrike Metzger; Eric Levy; Marie-Aude Lefrère-Belda; C. Bensaid


Ultrasound in Medicine and Biology | 2016

Supersonic Shear Wave Elastography of Response to Anti-cancer Therapy in a Xenograft Tumor Model

Foucauld Chamming's; Marie-Aude Lefrère-Belda; Heldmuth Latorre-Ossa; Victor Fitoussi; Alban Redheuil; Franck Assayag; Laetitia Pidial; Jean-Luc Gennisson; Mickael Tanter; C.A. Cuenod; L. Fournier


Gynecologie Obstetrique & Fertilite | 2011

Validation externe des critres de Timmerman sur une srie de 122tumeurs ovariennes

Khadija Fathallah; Cyrille Huchon; Anne Sophie Bats; Ulrike Metzger; Marie-Aude Lefrère-Belda; C. Bensaid; Fabrice Lecuru

Collaboration


Dive into the Marie-Aude Lefrère-Belda's collaboration.

Top Co-Authors

Avatar

Ulrike Metzger

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

C. Bensaid

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anne-Sophie Bats

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Denys Clément

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

F. Lecuru

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gilles Chatellier

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

S. Oudard

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Alban Redheuil

Paris Descartes University

View shared research outputs
Researchain Logo
Decentralizing Knowledge